Trademark: OXBRYTA
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for OXBRYTA
We do not have any records of a proof of use for OXBRYTA at this moment.
Possible trademark infringements of OXBRYTA
Basic Information about OXBRYTA
- Serial Number
- 87721060
- Filing Date
- 14 Dec 2017
- Registration Number
- 5973583
- Registration Date
- 28 Jan 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of OXBRYTA on the blockchain with WikiTrademarks.io.
- First use of OXBRYTA anywhere
- OXBRYTA was first used on 26 Nov 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns OXBRYTA?
1. Global Blood Therapeutics, Inc. South San Francisco CA
2. Global Blood Therapeutics, Inc. South San Francisco CA
3. Global Blood Therapeutics, Inc. South San Francisco CA
Correspondent
- Harold Milstein
- SHEPPARD MULLIN RICHTER & HAMPTON LLP
- 1540 El Camino Real, Suite 120
- Menlo Park CA 94025
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io